Prostate-derived circulating microRNAs add prognostic value to prostate cancer risk calculators.
Ontology highlight
ABSTRACT: Prostate cancer is the second leading cause of malignancy-related deaths among American men. Active surveillance is a safe option for many men with less aggressive disease, yet definitively determining low-risk cancer is challenging with biopsy alone. Herein, we sought to identify prostate-derived microRNAs in patient sera and serum extracellular vesicles, and determine if those microRNAs improve upon the current clinical risk calculators for prostate cancer prognosis before and after biopsy. Prostate-derived intracellular and extracellular vesicle-contained microRNAs were identified by small RNA sequencing of prostate cancer patient explants and primary cells. Abundant microRNAs were included in a custom microRNA PCR panel that was queried in whole serum and serum extracellular vesicles f
SUBMITTER: Zenner ML
PROVIDER: S-EPMC10938556 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA